Through successfully establishing FTO‐knockdown and FTO‐overexpressed human bladder cancer cells, we revealed that FTO is oncogenic, as demonstrated by its ability to stimulate cell viability and tumor growth in bladder cells. The gene discussed is FTO; the disease is urinary bladder carcinoma.